SipNose
SipNose
Develops non-invasive direct nose-to-brain drug delivery systems for neurological disorders.
Rate
About
SipNose is focused on creating innovative non-invasive direct nose-to-brain delivery systems designed to treat neurological disorders. Their flexible platform is adaptable for both clinical and home use, catering to pediatric, adult, and geriatric patients. The company has established a device master file with the FDA.
Technology stack
detected 2026-06-29Email
Google Workspace
Hosting
self_managed
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does SipNose do?
SipNose is focused on creating innovative non-invasive direct nose-to-brain delivery systems designed to treat neurological disorders. Their flexible platform is adaptable for both clinical and home use, catering to pediatric, adult, and geriatric patients. The company has established a device master file with the FDA.
Where is SipNose headquartered?
SipNose is headquartered in San Diego, United States.
When was SipNose founded?
SipNose was founded in 2011.
What industry does SipNose operate in?
SipNose operates in Healthcare, Drug Delivery, Life Sciences, Neurology, MedTech, HealthTech.
How many employees does SipNose have?
SipNose has approximately 2 people on record.